'High psa' presentation slideshows

Carrie Bennette (on behalf of Andrew Vickers) University of Washington

How do we know whether a marker or model is any good? A discussion of some simple decision analytic methods. Carrie Bennette (on behalf of Andrew Vickers) University of Washington. Overview of talk. Marker research in cancer: state of the science

363 views • 25 slides

Carrie Bennette on behalf of Andrew Vickers

How do we know whether a marker or model is any good? A discussion of some simple decision analytic methods. Carrie Bennette on behalf of Andrew Vickers Pharmaceutical Outcomes Research and Policy Program (PORPP) University of Washington. Overview of talk.

333 views • 25 slides

Non-cancerous Reasons for High PSA

199 views • 7 slides

Poorly differentiated low PSA prostate cancer: Evaluation of survival and treatment outcomes

No. 016. Poorly differentiated low PSA prostate cancer: Evaluation of survival and treatment outcomes . Alexander Jay, Carole Pinnock , Tina Kopsaftis , David Tamblyn and Kim Moretti Repatriation General Hospital, South Australia, Prostate Cancer Clinical Outcomes Collaboration.

184 views • 1 slides